Catherine Bollard - Jun 1, 2023 Form 4 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Director
Signature
/s/ Michael Gerard, Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 07:30 AM
Previous filing
Oct 18, 2022
Next filing
Jun 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to Buy) Award $0 +22K $0.00 22K Jun 1, 2023 Common Stock 22K $11.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 1, 2024 or (ii) the date of the next annual meeting of the Corporation's stockholders.